1 / 4

HYPOKALEMIA MANAGEMENT

Ghazalah Malik, MD PGY 1. HYPOKALEMIA MANAGEMENT. Preparations:. Oral: Salt substitutes contain 50 to 65 mEq per 5 mL IV: KCL can be added in intravenous fluids at concentrations of 20 to 40 meq per liter of fluid through a peripheral vein. A saline solution is preferred over Dextrose.

jamal-bowman
Télécharger la présentation

HYPOKALEMIA MANAGEMENT

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Ghazalah Malik, MD PGY 1 HYPOKALEMIAMANAGEMENT

  2. Preparations: Oral: Salt substitutes contain 50 to 65 mEq per 5 mL IV: KCL can be added in intravenous fluids at concentrations of 20 to 40 meq per liter of fluid through a peripheral vein. A saline solution is preferred over Dextrose.

  3. Treatment Asymptomatic, potassium >3 mEq/L 10-20meq of KCL 2-4 times a day. Mild to moderate symptoms or potassium <3.0 mEq/L Oral replacement of KCL 40-60 meq of KCL 3-4 times a day. Severe symptoms or unable to take oral medication, or potassium <2.5meq/l : A maximal intravenous repletion rate 10 to 20 mEq/h, and maximal concentration of 100 to 200 meq/L (prepared in 100 mL). Follow the serum potassium concentration closely. Continuous ECG monitoring in patients receiving potassium at 10 to 20 meq/h or faster.

  4. Thank you

More Related